Lyka Labs gets CDSCO nod to manufacture & market Tofacitinib Ointment

Lyka Labs gets CDSCO nod to manufacture & market Tofacitinib Ointment

by admin- Tuesday, October 10th, 2023 03:03:31 PM

 

Lyka Labs received the product permission from the Central Drugs Standard Control Organization of India to Manufacture and Market Tofacitinib Ointment 2% w/w.

The Company has received this permission after correctly finishing the Clinical Trial on one hundred twenty five sufferers across eight Clinical Trial Centers inside India.

News Updates